Simplifying Global Compliance
Fees, Snags in Russia Drive Off Trial Sponsors
Clinical Trials Advisor
Costly local clinical trials required to register both novel and generic drugs in Russia are discouraging clinical trials in that country, according to the Russia-based Association of Clinical Trials Organizations (ACTO).
To View This Article:
Subscribe To Clinical Trials Advisor
Buy This Article Now
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing